Concepedia

Utthara Nayar

UN

Statistics

Publications

10

Citations

1.1K

H-Index

10

Active since

2013

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Broad Institute

Brigham and Women's Hospital

Howard Hughes Medical Institute

Utthara Nayar is an author at Dana-Farber Cancer Institute specializing in oncology, molecular oncology, and medicine.

Publications per year

2013–2023

10

Publications

10

The Genomic Landscape of Intrinsic and Acquired Resistance to Cyclin-Dependent Kinase 4/6 Inhibitors in Patients with Hormone Receptor–Positive Metastatic Breast Cancer

Seth A. Wander, Ofir Cohen, Xueqian Gong et al. · Cancer Discovery · 2020 · 433 citations · Full text

Medicine, Cancer Biology, Oncology +17

Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies

Utthara Nayar, Ofir Cohen, Christian Kapstad et al. · Nature Genetics · 2018 · 239 citations

Medicine, Cancer Biology, Oncology +14

Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer

Pingping Mao, Ofir Cohen, Kailey J. Kowalski et al. · Clinical Cancer Research · 2020 · 185 citations

Medicine, Molecular Genetics, Oncology +17

Targeting the Hsp90-associated viral oncoproteome in gammaherpesvirus-associated malignancies

Utthara Nayar, Pin Lü, Rebecca Goldstein et al. · Blood · 2013 · 74 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

Defining the landscape of ATP-competitive inhibitor resistance residues in protein kinases

Nicole S. Persky, Desiree Hernandez, Lisa Brenan et al. · Nature Structural & Molecular Biology · 2020 · 63 citations

Life Sciences, Biochemistry, Molecular Biology +12

1–5 of 10